Trial Profile

A Pilot Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 Aug 2023 According to a Cognition Therapeutics media release, published confirmatory evidence from this SNAP Study in Translational Neurodegeneration.
10 Mar 2022 According to a Cognition Therapeutics media release, the company plans to publish complete Phase 1b SNAP results in a peer-reviewed journal later this year.
10 Mar 2022 According to a Cognition Therapeutics media release, data form this trial will be presented at the upcoming AD/PD 2022: the 16th International Conference on Alzheimer's & Parkinson's Diseases.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com